Tevogen Bio Pioneers AI-Driven Immunotherapy International Patent Publication and New Headquarters Propel Inn... | CSIMarket News
CSI Market
Sign In | Register

Tevogen Bio Pioneers AI-Driven Immunotherapy International Patent Publication and New Headquarters Propel Inn...

Published | Modified
CSIMarket Newsroom | CSIMarket.com
Illustrative image

WARREN, N.J., July 18, 2025’ Tevogen Bio Holdings Inc. (Nasdaq: TVGN), a biotech company specializing in innovative immunotherapy solutions, has made significant strides in artificial intelligence as it merges cutting-edge technology with healthcare. Recently, the International Bureau of the World Intellectual Property Organization (WIPO) published Tevogen’s international patent application

Sources for this article: Based on Tevogen Bio Holdings Inc ’s official statement and Competitive Environment Analysis by CSIMarket.com
For details on how CSIMarket validates financial and corporate news, please review our Editorial Standards & Fact-Checking Policy .
Tags:
#ProductServiceNews, #TevogenHowever0000, #competitors, #Tevogen.AI0000, #Patent0000, #ArtificialIntelligence0000, #Product/ServicesAnnouncementbusinessnewsbusinessnewsbusinessnewsbusinessnews, #TVGN, #Tevogen Bio Holdings Inc, #Biotechnology & Pharmaceuticals
Share this article:
X LinkedIn Facebook Email
Link copied to clipboard.

Comments

Comments are available to active subscribers. Subscribe or Log in.
Get the full CSIMarket dataset: Subscribe API License